title: Effects of sometribove on performance, carcass composition, and chemical blood characteristics of dairy calves.
abstract: Ten intact male Holstein calves averaging 75 kg of BW and 59 d of age were used to study the effects of daily injections of 0 (control) or 10 mg of sometribove (recombinant methionyl bST) for 6 wk on performance, health, carcass composition, N metabolism, chemical blood characteristics, and hormone profiles. Average daily gain, feed intake, feed:gain ratio, and height at withers, hip, and hock were not influenced by bST. Carcasses from bST-treated calves contained 5% more protein and 36% less lipid than controls. Circulating concentrations of Ca, P, glucose, urea N, alkaline phosphatase, creatine phosphokinase, insulin-like growth factor-I, and insulin were not affected by bST. Packed cell volume was decreased about 7% (29.9 vs. 32.4%) in the bST calves. Hormone injection did not adversely affect health of the calves as measured by body temperature and by pulse and respiration rates. The most profound effects of sometribove were a reduction in carcass lipid and an increase in body proteins. These effects may be of some practical importance when leanness of carcass is desirable.
authors.affiliation: Department of Animal and Dairy Science, University of Georgia, Athens 30602.
authors.forename: M W
authors.initials: MW
authors.lastname: Neathery
authors.forename: C T
authors.initials: CT
authors.lastname: Crowe
authors.forename: G F
authors.initials: GF
authors.lastname: Hartnell
authors.forename: J J
authors.initials: JJ
authors.lastname: Veenhuizen
authors.forename: J O
authors.initials: JO
authors.lastname: Reagen
authors.forename: D M
authors.initials: DM
authors.lastname: Blackmon
mesh_terms: D000818:Animals; D001774:Blood Chemical Analysis / Q000662:veterinary; D001786:Blood Glucose / Q000032:analysis; D001823:Body Composition / Q000187:drug effects*; D002417:Cattle / Q000097:blood / Q000254:growth & development*; D004435:Eating / Q000187:drug effects; D013006:Growth Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006400:Hematocrit / Q000662:veterinary; D006728:Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D019382:Human Growth Hormone; D007279:Injections, Subcutaneous / Q000662:veterinary; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D001786:Blood Glucose; D006728:Hormones; D011994:Recombinant Proteins; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone